Profile data is unavailable for this security.
About the company
IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.
- Revenue in GBP (TTM)6.67m
- Net income in GBP-1.18m
- Incorporated1995
- Employees89.00
- LocationIXICO PLC4th Fl, Griffin Court, 15 Long LaneLONDON EC1A 9PNUnited KingdomGBR
- Phone+44 20 3763 7499Fax+44 20 7209 2473
- Websitehttps://ixico.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Nuformix PLC | 0.00 | -436.95k |
ReNeuron Group Plc | 249.00k | -5.07m |
N4 Pharma PLC | 1.95k | -1.28m |
Hellenic Dynamics PLC | -100.00bn | -100.00bn |
Fusion Antibodies PLC | 1.58m | -2.84m |
TheraCryf PLC | 838.00k | -3.35m |
Oxford Cannabinoid Tchnlgs Hldngs PLC | 0.00 | -4.24m |
IXICO PLC | 6.67m | -1.18m |
ValiRx Plc | 0.00 | -2.41m |
BSF Enterprise PLC | 12.94k | -1.50m |
Cizzle Biotechnology Holdings PLC | 0.00 | -1.72m |
Genflow Biosciences PLC | 0.00 | -1.18m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
BGF Investment Management Ltd.as of 04 Dec 2023 | 8.92m | 18.46% |
Octopus Investments Ltd.as of 04 Dec 2023 | 6.41m | 13.25% |
Canaccord Genuity Wealth Ltd.as of 30 Mar 2021 | 4.68m | 9.69% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Feb 2024 | 1.76m | 3.63% |
City Asset Management Plcas of 29 Jan 2024 | 1.43m | 2.95% |
ICBC Standard Bank Plcas of 01 Feb 2024 | 610.00k | 1.26% |
Pilling & Co. Stockbrokers Ltd.as of 01 Feb 2024 | 267.00k | 0.55% |
HSBC Global Asset Management (UK) Ltd.as of 01 Feb 2024 | 223.00k | 0.46% |
Acadian Asset Management LLCas of 01 Feb 2024 | 151.00k | 0.31% |
BG Fund Management Luxembourg SAas of 01 Feb 2024 | 137.00k | 0.28% |